Publication | Closed Access

A phase I/II trial of interleukin-15–stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors

Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationHematologyImmunologyStem Cell TherapiesPhase I/ii TrialImmunotherapyMedicineCell TransplantationNatural Killer Cells